Viridian Therapeutics Inc (VRDN) (Q3 2026) Earnings Call Highlights: Lumvoa's Strong Debut With ...
Viridian Therapeutics Inc (VRDN) kicked off its Lumvoa launch with more than 100 patients treated and over $955 million in cash to fund operations through profitability. Related Stocks: VRDN ,